There Is Still Room For Community Health Systems Inc. (CYH) to Improve Its Value – Let’s Wait for Clarity

Community Health Systems Inc. (NYSE: CYH) closed the day trading at $3.14 down -5.99% from the previous closing price of $3.34. In other words, the price has decreased by -$0.2000 from its previous closing price. On the day, 1011589 shares were traded.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

For a better understanding of CYH, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.20 and its Current Ratio is at 1.40.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Loop Capital on June 17, 2022, initiated with a Hold rating and assigned the stock a target price of $5.

On June 15, 2022, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $7.50 to $5.50.

On March 29, 2022, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $12.Wells Fargo initiated its Equal Weight rating on March 29, 2022, with a $12 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 02 when SMITH WAYNE T bought 800,000 shares for $2.94 per share. The transaction valued at 2,352,000 led to the insider holds 4,059,196 shares of the business.

SMITH WAYNE T bought 200,000 shares of CYH for $600,000 on Aug 01. The Executive Chairman now owns 3,259,196 shares after completing the transaction at $3.00 per share. On Jun 02, another insider, Ely James S. III, who serves as the Director of the company, bought 10,000 shares for $5.00 each. As a result, the insider paid 50,000 and bolstered with 301,299 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03.

Stock Price History:

Over the past 52 weeks, CYH has reached a high of $14.74, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is 2.6468, while the 200-Day Moving Average is calculated to be 5.9718.

Shares Statistics:

Over the past 3-months, CYH traded about 2.47M shares per day on average, while over the past 10 days, CYH traded about 1.69M shares per day. A total of 129.14M shares are outstanding, with a floating share count of 126.20M. Insiders hold about 3.40% of the company’s shares, while institutions hold 82.40% stake in the company. Shares short for CYH as of Oct 13, 2022 were 11.38M with a Short Ratio of 11.49M, compared to 9.7M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 8.45% and a Short% of Float of 10.87%.

Earnings Estimates

Current recommendations for the stock of the company come from 10 analysts. On average, analysts expect EPS of $0.45 for the current quarter, with a high estimate of $0.81 and a low estimate of -$0.09, while EPS last year was $1.15. The consensus estimate for the next quarter is $0.02, with high estimates of $0.17 and low estimates of -$0.37.

Analysts are recommending an EPS of between -$1.83 and -$3.09 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$0.16, with 10 analysts recommending between $1.21 and -$1.93.

Revenue Estimates

10 analysts predict $3.18B in revenue for the current quarter. It ranges from a high estimate of $3.27B to a low estimate of $3.11B. As of the current estimate, Community Health Systems Inc.’s year-ago sales were $3.23B, an estimated decrease of -1.70% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $3.2B, an increase of 2.30% over than the figure of -$1.70% in the same quarter last year. There is a high estimate of $3.28B for the next quarter, whereas the lowest estimate is $3.1B.

A total of 11 analysts have provided revenue estimates for CYH’s current fiscal year. The highest revenue estimate was $12.36B, while the lowest revenue estimate was $12.12B, resulting in an average revenue estimate of $12.26B. In the same quarter a year ago, actual revenue was $12.37B, down -0.90% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $12.82B in the next fiscal year. The high estimate is $13.19B and the low estimate is $12.46B. The average revenue growth estimate for next year is up 4.50% from the average revenue estimate for this year.